E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2512 - ESOC25-1132 REGISTRY OF ISCHEMIC STROKE IN THE INTERNAL MEDICINE DEPARTMENT OF A TERTIARY CARE CENTER IN MEXICO CITY Jose Cambron-Jimenez 1 , Ricardo Santiago-Ramirez 1 , Samantha Pineda Venegas 1 1 Hospital Regional Licenciado Adolfo Lopez Mateos, Mexico City, Mexico Background and Aims: Stroke is a leading cause of morbidity and mortality in Mexico
It doesnt remove everything, but it gives a far broader improvement than filtration and chlorination alone
This is a metabolic pathway that neither GLP-1 nor GIP activation can access with the same potency
479 Over a decade later, Pegylated IFN-2b, polyethylene glycol-modified IFN-2b with a longer half-life also obtained FDA approval, although still with low efficacy and sever toxicity
K.SanchezD
Intravenous reduced GSH supplementation reverses endothelial dysfunction in patients with atherosclerosis enhancing NO activity and NO-mediated vasodilation (218)
